fda ruling tirzepatide US judge denies injunction, restricting copies of Lilly weight-loss drug The FDA is proposing the

This collaboration reflects whats possible globally when drugmakers, biotech companies, and diagnostic leaders partner with consumer platforms to support scaled distribution of their latest medical innovations, Dudum continued

Salicylate intoxication

The phase 3 weight loss study for Retatrutide is expected to finish in early 2026, paving the way for its potential approval and widespread use

Always consult with a qualified healthcare provider or pharmacist before starting, stopping, or changing any medication

Discovery of the non-incretin peptide hormone A recently published study by a team of scientists from Stanford University identified BRP using Peptide Predictor, a computational tool that the team developed to systematically map the proteolytic peptide fragments formed through cleavage by prohormone convertases